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Abstract
Background: In Schizosaccharomyces pombe, copper uptake is carried out by a heteromeric complex formed by the Ctr4
and Ctr5 proteins. Copper-induced differential subcellular localization may play a critical role with respect to fine tuning the
number of Ctr4 and Ctr5 molecules at the cell surface.
Methodology/Principal Findings: We have developed a bimolecular fluorescence complementation (BiFC) assay to analyze
protein-protein interactions in vivo in S. pombe. The assay is based on the observation that N- and C-terminal subfragments
of the Venus fluorescent protein can reconstitute a functional fluorophore only when they are brought into tight contact.
Wild-type copies of the ctr4
+ and ctr5
+ genes were inserted downstream of and in-frame with the nonfluorescent C-terminal
(VC) and N-terminal (VN) coding fragments of Venus, respectively. Co-expression of Ctr4-VC and Ctr5-VN fusion proteins
allowed their detection at the plasma membrane of copper-limited cells. Similarly, cells co-expressing Ctr4-VN and Ctr4-VC
in the presence of Ctr5-Myc12 displayed a fluorescence signal at the plasma membrane. In contrast, Ctr5-VN and Ctr5-VC co-
expressed in the presence of Ctr4-Flag2 failed to be visualized at the plasma membrane, suggesting a requirement for a
combination of two Ctr4 molecules with one Ctr5 molecule. We found that plasma membrane-located Ctr4-VC-Ctr5-VN
fluorescent complexes were internalized when the cells were exposed to high levels of copper. The copper-induced
internalization of Ctr4-VC-Ctr5-VN complexes was not dependent on de novo protein synthesis. When cells were transferred
back from high to low copper levels, there was reappearance of the BiFC fluorescent signal at the plasma membrane.
Significance: These findings reveal a copper-dependent internalization and recycling of the heteromeric Ctr4-Ctr5 complex
as a function of copper availability.
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Introduction
Given the physiological demands for copper across the biome,
both unicellular and multicellular organisms share the require-
ment for acquiring sufficient levels of copper for cell development
and proliferation [1]. Copper serves as a catalytic or a structural
cofactor for many of the enzymes that are intimately linked to
essential cellular functions, including the ones involved in
respiration, antioxidant defense, iron transport and the bioactiva-
tion of enzymes and hormones [2,3]. Paradoxically, when present
in excess, copper becomes a potent cytotoxin due to its ability to
react with hydrogen peroxide in a reaction that produces
detrimental hydroxyl radical [4]. Therefore, it is critical that
organisms maintain homeostatic mechanisms to acquire sufficient
amounts of copper, yet prevent its accumulation to toxic levels.
Eukaryotes from yeast to humans use the copper transporter
(Ctr) family of transporters for uptake of copper across the plasma
membrane [5]. Although Ctr amino acid sequences exhibit a
limited overall sequence homology between family members, most
of the Ctr transporters share the following overall features. An
extracellular N-terminal region of variable length contains
methionine residues arranged as MX2M and/or MXM motifs
(denoted Mets motifs) [5]. A first transmembrane span is
connected to a second transmembrane span by an intracellular
loop of variable length. Transmembrane spans 2 and 3 are joined
by a short linker region. Transmembrane span 2 contains a highly
conserved MX3M motif that is essential for function in copper
transport, whereas transmembrane span 3 possesses a conserved
GX3G motif that is required for the trimeric assembly of Ctr
molecules [6,7]. An intracellular C-terminal tail of variable length
possesses, in general, some cysteine and histidine residues that may
be involved in copper binding [1].
The fact that sequences of Ctr proteins vary considerably in both
length and composition may explain the reason why a number of
studies have reported various mechanisms for post-transcriptional
regulation of these proteins [8–11]. Studies in the baker’s yeast
Saccharomyces cerevisiae have shown that copper is taken up through
two high affinity copper transporters, Ctr1 and Ctr3 [12–14].
Although Ctr1 and Ctr3 are functionally redundant, these two
plasma-membrane proteins mediate copper uptake independently
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differently regulated, as compared to Ctr1, in terms of copper levels
[8,14]. Ctr3 steady-state levels at the cell surface are stable under
both low and high copper concentrations, whereas Ctr1 has been
reported to undergo different modes of regulation in response to
exogenous copper [8,14–16]. One study indicated that Ctr1 is
subjected to two forms of post-translational regulation: endocytosis
and proteolytic degradation [8]. Ctr1 endocytosis is induced when
cells are exposed to 0.1 to 1 mM copper, whereas Ctr1 degradation
occurs in response to copper concentrations of 10 mM or more.
Cells defective in endocytosis, due to mutations in the general
endocytosissystem,stillundergocopper-stimulatedCtr1proteolysis,
suggesting that degradation occurs at the plasma membrane via a
non-classical degradative pathway [8]. The observation that Ctr1
undergoes copper-induced endocytosis was confirmed by a second
study [15]. The second investigation concluded that Ctr1 is
ubiquitinylated in a copper- and Rsp5-dependent manner.
Consequently, the copper-dependent recognition of Ctr1 by the
Rsp5 ubiquitin ligase, which is required for ubiquitylation and
degradation of a wide variety of transmembrane proteins, is
followed by the delivery of Ctr1 to the lumen of the vacuole, and
then by its subsequent degradation by vacuolar proteases [15].
Unlike these first two reports, a third study indicated that the Ctr1
transporterisneitherregulatedatthelevelofsubcellularlocalization
nor endocytosed by copper [16]. Instead, this study proposed a
model in which excess copper induces conformational changes in
thecytosolicC-terminaltailofCtr1,inhibitingthepassage ofcopper
across the plasma membrane [16].
In mammals, Ctr transporters represent an important point of
regulation with which to adjust the intracellular concentration of
copper as a function of environmental copper availability [1,3].
However, as in the case of S. cerevisiae Ctr1, the proposed
mechanisms of post-translational regulation of CTR1 in human
(hCTR1) and mice (mCTR1) differed between studies [9–11,17].
In human embryonic kidney (HEK293) cells, it has been reported
that high copper levels trigger endocytosis and degradation of
hCTR1 [9,18]. Other experiments have revealed that only a
fraction of hCTR1 is internalized in response to copper, and that
hCTR1 internalization is accompanied by its recycling to the
plasma membrane when the cells undergo a shift from high to low
copper levels [17]. Other imaging studies have shown that high
copper levels have no effect on hCTR1 localization at the cell
surface [10,11]. Conversely, other reports have localized endog-
enous hCTR1 and mCTR1 both at the plasma membrane and in
association with as-yet undefined intracellular vesicles [10,19].
Copper is transported by a dual partner complex formed by two
integral membrane proteins encoded by the ctr4
+ and ctr5
+ genes in
Schizosaccharomyces pombe [20–22]. A clear interdependence between
Ctr4 and Ctr5 has been established, since the trafficking of either
protein to the cell surface requires the concomitant trafficking of
the other [21,22]. Analysis of fission yeast cells expressing Ctr4 and
Ctr5 proteins in which their N-terminal regions have been
mutated, revealed that at least one N-terminal region provided
by either protein suffices for copper transport [22]. Transcription
of the ctr4
+ and ctr5
+ genes is regulated by copper availability via
the copper sensing transcription factor 1 (Cuf1) [21,23]. These
genes are induced under conditions of copper starvation, and are
turned off under conditions of copper repletion. Because studies in
S. cerevisiae and mammalian cell lines have suggested that Ctr
proteins appeared to be post-translationally regulated, we
examined whether the S. pombe heteromeric Ctr4–Ctr5 transport
system was subjected to a form of post-translational regulation in
response to changes in copper levels. To begin to address this
question, we have developed a bimolecular fluorescence comple-
mentation (BiFC) assay [24,25] for use in fission yeast, allowing us
to study the Ctr4–Ctr5 complex in living cells as a function of
copper availability. Using this method, we determined that the
Ctr4 and Ctr5 proteins at the plasma membrane underwent
internalization from the cell surface after copper addition. This
copper-mediated internalization of the Ctr4–Ctr5 complex was
reversible, and was not dependent on de novo protein synthesis.
Collectively, our results strongly suggest that copper-dependent
internalization and recycling may be an important mechanism
with respect to fine tuning of the number of Ctr4–Ctr5 molecules
present at the plasma membrane in fission yeast.
Results
BiFC system for visualizing the Ctr4–Ctr5 complex in S.
pombe in vivo
Two integral membrane proteins, Ctr4 and Ctr5, form a copper
transporting complex at the cell surface of S. pombe that is required
for growth under low copper conditions [21,22]. Previous studies
have revealed that cells harboring a deletion of either ctr4
+ or ctr5
+
are defective in high affinity copper uptake [21]. Consistently,
these mutant cells exhibit phenotypes linked with copper
deficiency, including the inability to grow on respiratory carbon
sources and an impaired copper amine oxidase activity [21,22,26].
To begin to characterize this heteroprotein complex in vivo as a
function of copper availability, a BiFC approach was used in
fission yeast. To establish this method, the Venus protein was used
[27]. Venus is an improved version of the yellow fluorescent
protein (YFP) that contains amino acid substitutions, F46L/F64L/
M153T/V163A/S175G, which greatly accelerates its folding and
maturation [27]. Thus, fragments of Venus that fold rapidly form
BiFC complexes more efficiently than fragments of YFP that fold
slowly. Furthermore, Venus is the brightest fluorescent protein
that has been identified, allowing the highest intensity of BiFC
complex fluorescence [27]. Venus carboxyl-terminal fragment
(VC) and Venus amino-terminal fragment (VN) were fused to the
C-terminal ends of Ctr4 and Ctr5, respectively. Using either the
pBPade6
+ [22] or pJK148 [28] plasmid as a backbone, the ctr4
+
locus, which includes its own promoter, was inserted downstream
of and in-frame with the VC coding fragment of Venus (Fig. 1). A
flexible linker region was inserted between the DNA fragments
encoding Ctr4 and VC, and was derived from pFA6a-VC-
kanMX6 [25] (Fig. 1A). Similarly, the ctr5
+ gene, under the control
of its own promoter, was fused to the coding region of VN using a
flexible linker sequence derived from pFA6a-VN-kanMX6 [25]
(Fig. 1B). The working hypothesis was that the association between
the two nonfluorescent VC-tagged Ctr4 and VN-tagged Ctr5
proteins should trigger the assembly of a functional Venus
fluorophore, thereby allowing the detection of a BiFC signal by
fluorescence microscopy (Fig. 1C). Plasmids expressing the VC-
tagged Ctr4 and VN-tagged Ctr5 proteins were co-transformed
into a ctr4D ctr5D strain and the cells were analyzed for respiratory
competency as compared to cells transformed with functional
Ctr4-GFP (green fluorescent protein) and Ctr5-Myc12 proteins
[22]. As we have previously shown, the GFP-tagged Ctr4 and
Myc12-tagged Ctr5 proteins used in this study (as positive controls)
functionally complement the respiratory deficiency of a ctr4D ctr5D
strain in a manner indistinguishable from the ctr4
+ and ctr5
+ wild-
type alleles [22]. When Ctr4-VN and Ctr5-VC were co-expressed
in ctr4D ctr5D cells, they functionally complemented the respiratory
deficiency of the double mutant strain at the same level as did the
Ctr4-GFP and Ctr5-Myc12 fusion proteins (Fig. 2A). As expected,
the wild-type parental strain (used as a control), which harbored
chromosomal copies of the ctr4
+ and ctr5
+ genes, grew effectively
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complex to transport copper to the copper-requiring cytochrome c
oxidase (Fig. 2A). In contrast, a ctr4D ctr5D double mutant strain
that was co-transformed with two empty vectors, an empty vector
and ctr4
+-VC, or an empty vector and ctr5
+-VN, failed to grow on
respiratory carbon sources. This latter phenotype was presumably
due to the inability of the mutant cells to provide copper to the
cytochrome c oxidase [29].
When Ctr4-VC and Ctr5-VN were co-expressed in ctr4D ctr5D
cells under conditions of copper starvation, they generated a BiFC
signal at the plasma membrane in a manner similar to that of the
full-length version of Ctr4-GFP (that was co-transformed with
Ctr5-Myc12) (Fig. 2B). The specificity of the BiFC signal was
validated by the lack of a fluorescence signal when either the Ctr4-
VC or Ctr5-VN fusion protein was expressed in the absence of
either Ctr5-VN or Ctr4-VC, respectively (Fig. 2B). Furthermore,
no BiFC signal was detected in ctr4D ctr5D cells co-expressing two
unrelated proteins harboring the N- and C-terminal fragments of
Venus, such as VN-Php4 [30] and Ctr4-VC (Fig. 2B). These
results show that, consistent with their role in copper uptake, the
Ctr4-VC and Ctr5-VN fusion proteins generate a BiFC signal at
the plasma membrane in living cells.
Requirement of two Ctr4 monomers for localization at
the plasma membrane
Genetic trans-complementation, biochemical and structural pro-
jection experiments have demonstrated that Ctr transporters need to
trimerize in order to function in copper uptake [6,7,14,31]. Given the
fact that in S. pombe, both Ctr4 and Ctr5 proteins are physically
associated and interdependent for their localization at the plasma
membrane, we sought to determine whether Ctr4-VN and Ctr4-VC
co-localized at the plasma membrane in the presence of Ctr5-Myc12.
Co-expression of both ctr4
+-VN and ctr4
+-VC in cells expressing ctr5
+-
Myc12 allowed ctr4Dctr5D cellsto grow on a glycerol/ethanol medium
Figure 1. Design of the BiFC system used in S. pombe. A, Schematic representation of the ctr4
+-VC fusion gene including a linker region
(hatched box) that was inserted in-frame of and between the ctr4
+ allele and the nonfluorescent C-terminal (VC) coding fragment of Venus. The ctr4
+-
VC fusion allele is under the control of its native promoter. The numbers refer to the position of the nucleotides relative to the translational initiator
codon of ctr4
+. B, The VN DNA fragment was fused downstream of and in-frame with the ctr5
+ allele, which itself is under the control of its
endogenous promoter. The hatched box represents a DNA sequence derived from a linker region. The amino acid sequence of each linker (57 base
pairs (bps) for ctr4
+-VC and 30 bps for ctr5
+-VN) is depicted using the single-letter amino acid code. C, Schematic representation of Ctr4-VC and Ctr5-
VN fusion proteins in a membrane. Transmembrane proteins Ctr4-VC and Ctr5-VN are represented by round-shaped red and yellow cylinders,
respectively. Each cylinder represents a transmembrane domain. A third putative transmembrane protein partner (represented in dark) corresponds
to a putative monomer of Ctr4 or Ctr5. Ctr4-VC and Ctr5-VN close association reconstitutes a functional fluorophore.
doi:10.1371/journal.pone.0011964.g001
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was localized at the plasma membrane (Fig. 3B). We determined that
ctr4D ctr5Dcellsco-expressing onlyctr4
+-VN and ctr4
+-VCwere unable
to grow on glycerol/ethanol medium (Fig. 3A). Analysis of the
localization of the Ctr4-VN-Ctr4-VC complex by fluorescence
microscopy revealed that the BiFC signal was mainly detected in
the cytosol of the cells, without distinct fluorescence visible at the
periphery of the cells (Fig. 3B). Accordingly, these results corrobo-
rated previous findings by our group and others that both Ctr4 and
Ctr5 must be co-expressed to form a copper-transporting complex at
the plasma membrane [21,22]. As previously shown, Ctr4 is
mislocalized within the secretory pathway in the absence of Ctr5
[21,22]. Based on this result, we tested the co-expression of ctr5
+-VN
and ctr5
+-VC in cells expressing ctr4
+-Flag2.A l t h o u g hctr4D ctr5D cells
expressing these fusion alleles were able to grow on glycerol/ethanol,
no BiFC signal was detected at the plasma membrane (Fig. 3, C and
D). Instead, BiFC was only detected as a punctual fluorescence within
the cells. These results strongly suggest that only heteromeric protein
complexes including two Ctr4-Flag2 monomers with a single Ctr5-
VN, or two Ctr4-Flag2 monomers with a single Ctr5-VC, were
competent to confer growth on respiratory carbon sources.
Collectively, these data support the notion that two Ctr4 monomers
with a combination of one Ctr5 monomer are required for
localization of the heteromeric Ctr complex to the plasma membrane
and its proper functioning in copper transport in S. pombe.
Copper-induced internalization of the Ctr4–Ctr5 complex
To assess the effect of copper on the localization of the Ctr4–
Ctr5 heteromeric plasma membrane complex, ctr4D ctr5D cells co-
transformed with plasmids expressing the Ctr4-VC and Ctr5-VN
proteins were first grown to mid-logarithmic phase under low
copper conditions, so as to ensure a plasma membrane localization
of the Ctr4-VC-Ctr5-VN complex (Fig. 4A, T0). The cells were
then washed and resuspended in the same copper-limited medium
(160 nM), which was left unsupplemented or supplemented with
the copper chelator bathocuproinedisulfonic acid (BCS; 100 mM),
FeCl3 (100 mM) or CuSO4 at various concentrations (1, 25 or
100 mM), for 3 h. Results showed that when the cells were exposed
to 25 and 100 mM CuSO4, the Ctr4-VC-Ctr5-VN protein
complex accumulated intracellularly in a copper concentration-
dependent manner (Fig. 4A). The BiFC signal exhibited copper-
dependent internalization from the cell surface, with the
progressive appearance of vesicular fluorescence. In contrast,
following treatment with FeCl3 (100 mM) or BCS (100 mM) for
Figure 2. Co-expression of Ctr4-VC and Ctr5-VN functionally complements the respiratory deficiency of a ctr4D ctr5D mutant and
produces a BiFC signal at the plasma membrane. A, S. pombe cells harboring a ctr4D ctr5D double deletion were transformed with empty
vectors (v. alone), a vector alone (v. alone) and ctr4
+-VC, a vector alone and ctr5
+-VN, ctr4
+-VC and ctr5
+-VN,o rctr4
+-GFP and ctr5
+-MYC12. Cultures
were spotted onto YES media containing glucose or glycerol/ethanol (EtOH) and BCS (0, 5, 10, 20 and 25 mM). WT, isogenic wild-type (WT) strain
FY435 (ctr4
+ ctr5
+). B, BiFC signal of Ctr4-VC and Ctr5-VN fusion proteins at the plasma membrane. Yeast cells disrupted for ctr4
+ and ctr5
+ that
expressed individually, or in combination, the indicated tagged genes were grown in EMM medium containing BCS (100 mM) and analyzed by
fluorescence microscopy. As a positive control, co-expression of the Ctr4-GFP and Ctr5-Myc12 fusion proteins allowed Ctr4-GFP detection in the
plasma membrane. As an additional proof of the specificity of the BiFC, no Venus-associated fluorescence was detected when the unrelated ctr4
+-VC
and VN-php4
+ fusion alleles were co-expressed together. Cell morphology was examined through Nomarski optics.
doi:10.1371/journal.pone.0011964.g002
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membrane (Fig. 4A). To ascertain whether, like Ctr4-VC-Ctr5-
VN, Ctr4-GFP underwent a copper-dependent internalization
when it was co-expressed with Ctr5-Myc12 in the presence of high
copper concentrations, the above-mentioned cell growth protocol
was repeated using ctr4D ctr5D cells expressing Ctr4 and Ctr5
proteins that were tagged with GFP and Myc12, respectively.
Results revealed that, as visualized using the BiFC assay with Ctr4-
VC-Ctr5-VN, Ctr4-GFP exhibited copper-induced internalization
from the cell surface in response to exposure to 100 mM CuSO4
(Fig. 4B). In contrast, when cells co-transformed with plasmids
expressing the Ctr4-GFP and Ctr5-Myc12 proteins were left
untreated or were treated with BCS (100 mM), Ctr4-GFP
remained at the cell surface (Fig. 4B). The results indicate that
upon exposure of S. pombe to high copper conditions, Ctr4-VC-
Ctr5-VN heteromeric complexes underwent internalization from
the cell surface, producing BiFC signals that had the appearance of
cytoplasmic punctuate structures within the cell.
Copper-induced internalization of pre-existing
heteromeric Ctr4–Ctr5 molecules
Cells expressing ctr4
+-VC and ctr5
+-VN were treated with
cycloheximide to ensure that the cytoplasmic punctuate BiFC
signal was due to the copper-dependent internalization of pre-
existing Ctr4-VC-Ctr5-VN complexes from the cell surface and
not to the effect of copper on newly synthesized Ctr4-VC-Ctr5-
VN complexes arising from a pool of stable mRNA. Cytoplasmic
translation was inhibited by addition of cycloheximide (100 mg/
ml) for 30 min, followed by treatment with CuSO4 (25 mM) for 0,
1, 3, 4 and 6 h. Under these conditions, the Ctr4-VC-Ctr5-VN
complexes that were present at the cell surface were internalized in
response to copper treatment (Fig. 5A). This copper-stimulated
internalization was detectable after 3 h, and remained observable
for at least 6 h. The failure of cycloheximide to influence this
process indicated that copper-induced intracellular trafficking of
Ctr4-Ctr5 complexes was not dependent on the de novo synthesis of
proteins. Furthermore, Ctr4-VC-Ctr5-VN complexes were stable
at the cell surface when cells were grown under low copper
concentrations and in the presence of cycloheximide, indicating
that the Ctr4–Ctr5 complex internalization was specific to copper
treatment (Fig. 5B). We checked that the cycloheximide treatment
had an inhibitory growth effect on cells harboring Ctr4-VC-Ctr5-
VN complexes (Fig. 5C). Although cells grown in cycloheximide-
free medium containing copper (25 mM) showed 23% inhibition of
growth after 6 h of incubation, as compared to cells that were left
untreated (neither with copper nor cycloheximide), cells that had
Figure 3. Cells co-expressing Ctr4-VN and Ctr4-VC in the presence of Ctr5-Myc12 display a fluorescent signal at the plasma
membrane, whereas Ctr5-VN and Ctr5-VC co-expressed in the presence of Ctr4-Flag2 fail to interact at the plasma membrane. A, The
strain JSY22 (ctr4D ctr5D) was co-transformed with vectors alone (v. alone), integrative plasmids co-expressing only ctr4
+-VN and ctr4
+-VC,o rctr4
+-VN
and ctr4
+-VC in the presence of ctr5
+-MYC12. Cells were grown either for 5 days on YES medium in the presence of glucose or, for 9 days, on YES
medium in the presence of glycerol/ethanol (EtOH) containing or not BCS (25 mM). WT, parental wild-type strain FY435. B, ctr4D ctr5D cells co-
expressing the indicated fusion alleles were grown to an A600 of 0.5. At this optical density, BCS (100 mM) was added and the treated cultures were
incubated for 3 h at 30uC, and then visualized for BiFC by fluorescence microscopy. The cells were also examined by Nomarski microscopy for cell
morphology. C, JSY22 (ctr4D ctr5D) cells were co-transformed with vectors alone, or with ctr5
+-VN and ctr5
+-VC in the absence (v. alone) or the
presence of ctr4
+-FLAG2. Growth was tested on both fermentable (glucose) and non-fermentable (glycerol/ethanol) media that were either
supplemented, or not with BCS (25 mM). D, BiFC analysis of Ctr5-VN + Ctr5-VC and Ctr5-VN + Ctr5-VC + Ctr4-FLAG2 in ctr4D ctr5D cells. Representative
fluorescence images of BiFC are shown. Nomarski microscopy was used to determine cell morphology.
doi:10.1371/journal.pone.0011964.g003
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exhibited a much more pronounced growth inhibition (85%) at
this time point (6 h) (Fig. 5C). Because the growth rate of
cycloheximide-treated cells was significantly inhibited as compared
to control cells, we concluded that de novo protein synthesis was
blocked by cycloheximide in an effective manner. Taken together,
these results indicate that the localization of Ctr4–Ctr5 complexes
at the plasma membrane is regulated in response to copper
through the relocalization of the heteroprotein complex from the
cell surface to the cytoplasm.
Copper-dependent recycling of Ctr4–Ctr5 proteins
The above results revealed that, in response to high
concentrations of copper, Ctr4–Ctr5 complexes were internal-
ized in the cytoplasm. In order to test whether Ctr4-VC-Ctr5-
VN complexes recycled back to the plasma membrane under
conditions of low copper, cells were grown in the presence of
25 mM copper for 4 h, after which step (Fig. 6, T0), they were
examined as a function of copper availability. Following the
4 h incubation in the presence of exogenous copper, the cells
were harvested and then resuspended in basal medium in the
presence of cycloheximide (100 mg/ml) for 30 min. At this time
point, the localization of the BiFC signal was unchanged and
similar to that of the zero time point (T0, data not shown).
Following the 30 min exposure to cycloheximide, the cells
were divided into three groups. A first group was left
untreated, while the two other groups were incubated in the
presence of exogenous copper (25 mM) or BCS (250 mM).
When cells were starved for copper in the presence of BCS, the
BiFC signal returned to the plasma membrane (Fig. 6). The
possible implication of newly synthesized Ctr4-VC-Ctr5-VN
complexes was eliminated by pre-treatment with cyclohexi-
mide. In contrast, the incubation performed in the presence of
copper (25 mM) resulted in the detection of the BiFC signal in
cytoplasmic punctuated structures as observed at the onset of
the observations (T0, Fig. 6). Similarly, when the cells were re-
incubated in basal medium (untreated), there was an absence
of copper starvation-dependent recycling of Ctr4-VC-Ctr5-VN
to the plasma membrane (Fig. 6). Under this latter experi-
mental condition, the BiFC signal remained localized to the
cytosol and exhibited a punctuated distribution. The BiFC
data strongly suggest a model in which the elevation of copper
levels results in a copper-stimulated internalization of the
Ctr4–Ctr5 copper transport complex. In contrast, the Ctr4–
Ctr5 molecules that had been internalized in response to
excess copper undergo recycling back to the plasma mem-
brane in response to a transition from high to copper-limiting
conditions.
Figure 4. Copper-dependent internalization of the Ctr4-Ctr5 complex. A, Cells harboring a ctr4D ctr5D double deletion were co-transformed
with the ctr4
+-VC and ctr5
+-VN alleles. Co-transformed cells were grown in EMM containing 160 nM of copper (low Cu) to an A600 of 0.5 (T0), and then
were left untreated (low Cu), or were treated with BCS (100 mM), CuSO4 (1, 25, and 100 mM) (Cu) or FeCl3 (100 mM) (Fe). After being incubated for 3 h,
the cells were visualized by fluorescence microscopy (BiFC). The cells were also examined by Nomarski microscopy for cell morphology. B, ctr4D ctr5D
cells co-expressing the Ctr4-GFP and Ctr5-MYC12 fusion proteins were grown to mid-logarithmic phase in EMM copper-poor (160 nM) media (low Cu).
Cells were then incubated in the absence (low Cu) or the presence of CuSO4 (100 mM) or BCS (100 mM). After a 3 h treatment, the full-length Ctr4-GFP
protein was viewed by direct fluorescence microscopy (GFP). The corresponding Nomarski images are also shown for each GFP panel.
doi:10.1371/journal.pone.0011964.g004
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One purpose of the experiments described in this work was to
develop and utilize BiFC to study protein-protein interactions in
live fission yeast cells. The Ctr4–Ctr5 association was selected as a
proof-of-concept model, since this interaction has previously been
established in cells grown under conditions of copper starvation
[21,22]. Under copper-limiting conditions, studies have shown
that the simultaneous biosynthesis of Ctr4 and Ctr5 is required for
their appropriate targeting to the cell surface as a heteromeric
Figure 5. Preexisting Ctr4-Ctr5 complexes undergo internalization in response to high concentrations of copper. A, A double-
disruption strain (ctr4D ctr5D) was co-transformed with the ctr4
+-VC and ctr5
+-VN alleles. A mid-logarithmic phase culture (A600 of 0.5) was treated
with cycloheximide (100 mg/ml) for 30 min so as to inhibit protein synthesis, followed by treatment with CuSO4 (25 mM) for the indicated times. To
ensure the complete inhibition of protein synthesis, the cycloheximide treatment was repeated after 3 h of exposure of the cells to copper. The cells
were then analyzed by fluorescence microscopy (BiFC). Cell morphology was examined using Nomarski optics. B, Cells were cultured as described for
panel A, except that they were treated with cycloheximide only, without exposure of the cells to CuSO4. C, Growth of cells was assessed in liquid
cultures in the absence (untreated) or the presence of CuSO4 (25 mM), or a combination of CuSO4 and cycloheximide (100 mg/ml). All cultures were
restarted at an A600 of ,0.5. Data are the average of triplicate samples from three independent cultures. Error bars indicate the average 6 standard
deviation.
doi:10.1371/journal.pone.0011964.g005
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uptake [21,22]. In the present study, using the BiFC method to
investigate protein-protein interactions and localization within live
cells, we showed that the Ctr4–Ctr5 heterocomplex was regulated
post-translationally since copper induced its internalization.
However, copper-dependent transcriptional inhibition of ctr4
+
and ctr5
+ gene expression is more sensitive than post-translational
regulation of the Ctr4–Ctr5 complex. Copper, at concentrations as
low as 1 mM, can repress the transcription of ctr4
+ and ctr5
+
([23,32] and data not shown), whereas the same concentration had
no apparent effect on the localization of the heteromeric Ctr4–
Ctr5 complex at the cell surface (Fig. 4). The data we obtained
represent the more long term effects of elevated copper on the
Ctr4–Ctr5 transporting complex. Indeed, the copper-dependent
post-transcriptional internalization of the heteromeric Ctr4–Ctr5
complex was observed only 3 h after copper addition (Fig. 5). This
suggests that the copper-induced internalization of the Ctr4–Ctr5
heterocomplex is not the primary mechanism for inhibiting the
transport of copper. In fact, copper transport appears to be
uncoupled from target gene regulation. In this context, it has been
shown that transcriptional regulation is more sensitive than post-
translational regulation for both high affinity iron and zinc
transport systems in S. cerevisiae [33–35]. For instance, iron, at
levels as low as 1 to 10 mM, can repress transcription of the S.
cerevisiae FET3 gene by .90%, whereas the same concentrations
only had minimal effects on protein steady-state levels.
Structural and biochemical studies have revealed that mem-
brane proteins of the Ctr family exhibit a trimeric organization,
allowing the formation of a translocation path that includes nine
transmembrane domains [36]. In contrast to Ctr1 and Ctr3 from
S. cerevisiae [14,16,37], and human CTR1 [38], that self-trimerize
in the plasma membrane, Ctr4 and Ctr5 from S. pombe are
interdependent for co-localization at the cell surface and
participation in copper transport [21,22]. We co-expressed ctr4
+-
VN and ctr4
+-VC in cells expressing ctr5
+-Myc12 to better
characterize the nature of this copper-transporting complex in
living cells. Because this was the only pair of interacting proteins
that allowed their detection at the plasma membrane when co-
expressed with Ctr5, we proposed a model in which the formation
of a heteromeric Ctr4–Ctr5 complex required the presence of at
least two Ctr4 monomers with a combination of one Ctr5
monomer, resulting in a 2/1 (Ctr4/Ctr5) subunit ratio. However,
our data did not allow us to conclusively establish whether the
Ctr4–Ctr5 copper-transporting complex assembled strictly as a
trimer or whether it adopted a higher-ordered quaternary
structure at the cell surface. Based on a structural model of Ctr
transporters [7,36], it has been observed that Ctr4 possesses
residues at positions 236 (Phe) and 237 (Leu) in the third
transmembrane domain that may hinder the formation of a stable
homo-multimeric complex. Consequently, it has been proposed
that Ctr5 may ensure stable assembly of the copper transport
complex. Because Ctr5 was originally identified based on its ability
to alleviate a block in Ctr4 sorting to the plasma membrane, it is
quite likely that the Ctr5 protein is required for Ctr4 hetero-
oligomerization and to exit from the secretory pathway, where the
heterocomplex can mediate copper uptake into the cell. Studies
are currently ongoing in our laboratory to test this possibility.
One group has reported that the presence of excess copper at a
concentration of 10 mM rapidly induced the degradation of Ctr1
at the plasma membrane (half-life,30 min) in S. cerevisiae [8]. It
was suggested that the copper-dependent degradation of Ctr1
occured in the absence of endocytosis. Another group has shown
that at higher concentrations of copper (50 mM), Ctr1 was partially
internalized by endocytosis, with a small proportion of the
internalized protein being degraded 2 h after the addition of
copper [15]. Recently, an additional group has concluded that
within 30 min of exposure to excess copper (100 mM), plasma
membrane-associated Ctr1 levels were not significantly affected
[16]. These authors proposed a mechanism by which conforma-
tional changes in the C-terminal cytosolic tail of Ctr1 lead to
inhibition of the Ctr1-mediated copper uptake [16]. Consistent
with the proposed model, cells expressing altered forms of Ctr1 in
which the C-terminal cytosolic region was either truncated or
mutated were very sensitive to excess copper [16]. However, a
potential relocalization of Ctr1 following long periods of cell
exposure to copper (.30 min) has not yet been reported.
Nonetheless, site-directed mutagenesis has identified amino acid
residues within the Ctr1 C-terminal cytosolic tail that are
important for blocking the Ctr1-dependent copper uptake in
response to excess copper. Among these residues, five Cys located
at positions 304, 310, 312, 363 and 365, as well as a dileucine
motif (Leu-397 and Leu-398), have been shown as being required
for the inhibition of copper translocation across the plasma
membrane. Although S. pombe Ctr4 and Ctr5 function in high
affinity copper transport at the cell surface, their C-terminal
cytosolic tails are different in both length and amino acid sequence
composition as compared to that of S. cerevisiae Ctr1. The C-
terminal tail of Ctr1 contains 125 amino acid residues, whereas the
C-terminal cytosolic regions of Ctr4 and Ctr5 are shorter,
encompassing only 39 and 16 amino acid residues, respectively.
Ctr4 and Ctr5 do not contain a dileucine motif within their C-
termini. Furthermore, the C-terminal cytosolic region of Ctr4
lacks Cys residues, while that of Ctr5 contains a single Cys-Cys
motif located at positions 169 and 170. Because of the important
variations in both length and composition of residues between the
C-terminus of Ctr1 and the C-terminal cytosolic tails of Ctr4 and
Ctr5, it can be argued that some aspects of transporter regulation
differ between different family members. Analogous to recent
results with hCTR1 [17], the Ctr4–Ctr5 complex was observed to
undergo internalization and intracellular accumulation in response
to elevated environmental copper levels. Furthermore, as observed
in the case of hCTR1 [17], the heteromeric Ctr4–Ctr5 complex is
Figure 6. Ctr4-Ctr5 complexes recycle during a shift of high to
low copper concentrations. ctr4D ctr5D cells containing the tagged
ctr4
+-VC and ctr5
+-VN coding sequences were grown in EMM containing
CuSO4 (160 nM) for 16 h. The culture was then diluted (1610
7 cells/ml)
and incubated in the presence of CuSO4 (25 mM) for 4 h, at which time
(T0) the cells were washed twice and incubated in the presence of
cycloheximide (100 mg/ml) for 30 min. At this point, the culture was
divided into three treatment groups. A first group was left untreated
(2), while the two other were treated with 25 mM CuSO4 (Cu) or 250 mM
BCS, respectively. Nomarski microscopy was used to determine cell
morphology.
doi:10.1371/journal.pone.0011964.g006
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bioavailable exogenous copper.
It has been shown that either the deletion of the C-terminal
cytosolic tail of S. cerevisiae Ctr1 or the insertion of an epitope tag
within the same region of Ctr1 resulted in a structural perturbation
that inhibited its function in preventing excess copper uptake [16].
Consequently, cells expressing these mutant alleles exhibited a
copper-sensitive growth phenotype. Based on these observations,
we determined whether the VN or VC epitope-tagged versions of
the Ctr4 or Ctr5 proteins confered sensitivity to copper when
expressed in ctr4D ctr5D cells. We observed that cells constitutively
co-expressing ctr4
+-VN or ctr4
+-VC in combination with ctr5
+-VN or
ctr5
+-VC did not exhibit copper-sensitive growth phenotype (data
not shown). Indeed, when the tagged ctr4
+ and ctr5
+ alleles were
co-expressed in ctr4D ctr5D cells, they functionally complemented
the respiratory deficiency of the double mutant strain at the same
level as the ctr4
+ and ctr5
+ wild-type, untagged alleles (Fig. 2 and
data not shown). This important difference between the S. pombe
Ctr4–Ctr5 copper transport system and S. cerevisiae Ctr1 supports
the existence of distinct mechanisms for transporter regulation
between different family members.
At the present state of knowledge, the molecular process by
which the Ctr4–Ctr5 copper transport complex is stimulated to
undergo internalization and recycling in response to changes in
copper levels is unknown. We suggest that there are specific signals
in either Ctr4 or Ctr5, and additional cellular factors, that are
required for both the internalization of the Ctr4–Ctr5 complex
and its return to the plasma membrane. It has been shown that the
copper-regulated subcellular localization and transport function of
the human ATP7A/ATP7B copper ATPases and hCTR1 are
mechanistically coupled [1]. Consequently, it is tempting to
speculate that the Met-rich domains of Ctr4 and the Ctr4 residue
Met-122, which have been shown to play important roles in
copper assimilation [22], may also participate in the copper-
stimulated trafficking response of the heteromeric Ctr4–Ctr5
complex. Similarly, the Met-rich domains of Ctr5 and the Ctr5
Cys-X-Met-X-Met sequence may also be required for the post-
translational regulation of the Ctr4–Ctr5 complex [22]. The fact
that the sequence identity between Ctr4 and Ctr5 is relatively low
may signify that there are distinct mechanistic contributions from
both Ctr4 and Ctr5 in the copper-regulated trafficking of the
heteromeric protein complex. For example, either Ctr4 or Ctr5
may participate in molecular interactions with other partners that
play a critical role in both signaling and either endocytic or
exocytic movement in response to changes in copper levels. Future
studies will be needed to establish their respective mechanistic
contributions.
Materials and Methods
Strains and media
The S. pombe strains used in this study were the wild-type FY435
(h+ his7-366 leu1-32 ura4-D18 ade6-M210) and the ctr4D ctr5D
double mutant disruption strain (isogenic to FY435 plus
ctr4D::ura4
+ ctr5D::KAN
r) [22]. Under non-selective conditions, S.
pombe cells were grown in yeast extract plus supplements (YES)
containing 225 mg/l of adenine, histidine, leucine, uracil and
lysine. The fermentable carbon source YES medium contains 3%
glucose, whereas the non-fermentable carbon source YES-
glycerol/ethanol medium was prepared by replacing the glucose
in YES with a combination of 3% glycerol (v/v) and 2% ethanol.
When plasmid maintenance was necessary, the cells were grown in
Edinburgh minimal medium (EMM) lacking the specific amino
acids required for plasmid selection [39]. Unsupplemented EMM
contained 160 nM copper, unless otherwise stated. To test the
ability of transformed cells to grow on either a fermentable or a
non-fermentable carbon source, the indicated cells were grown to
mid-logarithmic phase and then spotted onto agar media
containing either glucose, or glycerol/ethanol with 0, 5, 10, 20
or 25 mM of the copper chelator bathocuproine disulfonic acid
(BCS). Spotted cells were grown either for 5 days on media
containing glucose, or for 9 days on media containing glycerol/
ethanol either with or without BCS.
Ctr4 plasmids
To generate thepBPctr4
+-VCplasmid, a BamHI-SacI polymerase
chain reaction (PCR)-amplified DNA segment containing the
nonfluorescent C-terminal (VC) coding fragment of Venus was
isolated from the pFA6a-VC155-KANMX6 plasmid [25] and then
inserted into the BamHI and SacI sites of the plasmid pBPctr4
+ [22].
A similar strategy was used to create the plasmid pBPctr4
+-VN,
except that a BamHI-SacI PCR-amplified DNA segment contain-
ing the nonfluorescent N-terminal (VN) coding fragment of Venus
was isolated from the pFA6a-VN173-KANMX6 plasmid [25]. The
pBPctr4
+-VN plasmid was digested with ApaI and SacI to isolate the
ctr4
+-VN fusion coding sequence, which was subsequently cloned
into the same restriction sites in plasmid pJK148 [28]. The resulting
plasmid was named pJKctr4
+-VN. The plasmid pBPctr4
+-Flag2 was
constructed by isolating the SacI-SalI fragment from pSPctr4
+-Flag2
[21]. This DNA restriction fragment contained both the ctr4
+-Flag2
fusion gene and its promoter region up to 737 nucleotides upstream
of the initiator codon of the ctr4
+ gene.
Ctr5 plasmids
To create a plasmid that had the ctr5
+ gene coupled with twelve
copies of the Myc epitope, the DNA fragment containing the ctr5
+
gene was isolated from the pSKctr5
+ plasmid [22] using PstI and
XmaI (isoschizomer of SmaI), and was then inserted into the
corresponding sites of pctr4
+-X-Myc12 [40]. By substituting the ctr5
+
promoter in place of the ctr4
+ promoter, the plasmid had the ctr5
+
promoter driving the expression of the ctr5
+-Myc12 fusion gene.
Once created, the ctr5
+-Myc12 fusion gene and its regulatory region
were isolated using PstI and XbaI, and were then inserted into the
corresponding sites of pJK148. The resulting plasmid was
designated pJKctr5
+-Myc12. Subsequently, using Asp718 and NotI
(enzymes with restriction sites that are located on either side of the
insert), the ctr5
+-Myc12 fusion gene was cloned into the Asp718/
NotI-cut pEA500 to generate pEActr5
+-Myc12. Next, using Asp718
and SacI, the ctr5
+-Myc12 fusion gene was inserted into an Asp718/
SacI-cut pSP1 to create pSP1ctr5
+-Myc12. To generate the
pSPctr5
+-VN plasmid, an XmaI-SacI PCR-amplified DNA seg-
ment containing the VN coding fragment was isolated from the
plasmid pFA6a-VN173-KANMX6 [25] and then substituted for
the XmaI-SacI restriction fragment present in the plasmid
pSP1ctr5
+-Myc12, thereby replacing the Myc epitope with the
VN fragment. To create a plasmid possessing the ctr5
+ gene in-
frame with the VC coding fragment of Venus, the ctr5
+ gene and
its promoter region was isolated from pSP1ctr5
+-VN by Asp718
and XmaI digestions. The purified Asp718-XmaI DNA fragment
was then cloned into the corresponding sites of pEA500 [41],
generating pEActr5
+. The coding sequence of VC was PCR
amplified from pFA6a-VC155-KANMX6 [25] and then inserted
into the XmaI and BamHI restriction sites of pEActr5
+, creating
pEActr5
+-VC.
Microscopic analysis of BiFC signals
ctr4D ctr5D double mutant cells co-expressing BiFC fusion
proteins were grown in EMM medium containing the appropriate
Ctr4-Ctr5 Complex Trafficking
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were grown to an A600 of ,0.5. These mid-logarithmic cells were
then incubated in the presence of CuSO4 (1, 25 or 100 mM), FeCl3
(100 mM), or BCS (100 mM). After a 3 h treatment, direct
fluorescence images for BiFC signal were taken using a fluorescein
isothiocyanate filter set (excitation band pass filter, 465–495 nm;
beam splitter, 505 nm; emission band pass filter, 515–555 nm).
Microscopy was performed with a Nikon Eclipse E800 epifluor-
escent microscope (Nikon, Melville, NY) equipped with a
Hamamatsu ORCA-ER cooled CCD camera (Hamamatsu,
Bridgewater, NJ). The cell fields shown in this study are
representative of at least five independent experiments.
Inhibition of protein synthesis
To terminate cytoplasmic translation, mid-logarithmic cells
(A600 of ,0.5) were treated with cycloheximide (100 mg/ml) for
30 min prior to addition of either copper or BCS. Because the
growth rate of cycloheximide-treated cells was inhibited, as
compared with control cells, it was considered that de novo protein
synthesis had been blocked by cycloheximide in an effective
manner.
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